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We incorporate a new section in Redox Biology, the Editors'
forum. The main objective is to attract short contributions related
to previously published articles that may help to clarify concepts,
open controversies or constructively criticize conclusions from a
speciﬁc article. The contribution will show a link to the related
article and may be accompanied by the appropriate response of
the authors to the commentary on their article.
The article by Drs. Cortese-Krott and Kelm [1] promoted an
extensive analysis by Dr. Tsikas about the optimal methodology to
characterize eNOS activity in red blood cells and its relevance for
the concepts put forward by Cortese-Krott and Kelm. The authors
were given the opportunity to respond to this commentary and
their answer is shown below the commentary. Indeed this is an
important question as the jury appears to be still out concerning
the existence of a NOS isoform in human red blood cells. Dr. Tsikas
makes a strong case on the validity of the gas chromatography-
mass spectrometry (GC-MS) NOS activity assay for a large set of
samples, including erythrocytes, and delves into the complex
chemistry involved. Drs. Cortese-Krott and Kelm lucidly respond
to Dr.Tsikas with equally powerful arguments. We are proud to
host this illuminating discussion on a complex chemical topic and
we invite all readers to follow this example and submit commen-
taries that may contribute to enhance progress in the under-
standing of challenging notions in the ﬁeld of redox biology.
http://dx.doi.org/10.1016/j.redox.2015.01.018
Can nitric oxide synthase activity be unequivocally
measured in red blood cells and platelets? if yes, by
which assay?
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To the Editor
I read with interest the article by Cortese-Krott and Kelm [1] who
reviewed and discussed the at ﬁrst glance paradoxical, yet potentially
important and formidably challenging issue of nitric oxide (NO)
synthesis from L-arginine by endothelial NO synthase (eNOS) in red
blood cells (RBCs), a possibly new erythrocrine function. In considera-
tion of the high concentration of hemoglobin in erythrocytes (about
10 mM) and the high afﬁnity of O2, NO and carbonmonoxide (CO) and
presumably of other gases to the heme group of hemoglobin, the
majority of scientists believes that RBCs behave toward NO as do
super-massive black holes behave against matter and even light, with
other words as “NO sinks”. Yet, in practice we see that RBCs are able to
export NO and other NO species that can ﬁnally exert cGMP-
dependent and cGMP-independent NO-related activities in the circu-
lation. With respect to this issue I fully agree with the statements,
arguments and conclusions by Cortese-Krott and Kelm in their review
article [1]. However, I do not agree with the authors on their argument
concerning the alleged chemistry of NOS-derived NO in RBCs and that
this particular NO chemistry may explain our failure to measure NOS
activity in human RBCs by means of a previously reported, fully-
validated [2] and cross-validated [3] gas chromatography-mass spec-
trometry (GC–MS) NOS activity assay.
The principle of our GC–MS NOS activity assay [2] used in vivo and
in vitro in blood cells including human RBCs [4] and platelets [3,5] and
the major reactions of NO and its major metabolites/reaction products,
nitrate and nitrite, are illustrated in Fig. 1. We use L-[guanidino-15N2]-
arginine as the substrate for NOS which oxidizes one of the two 15N-
labelled atoms of L-[guanidino-15N2]-arginine to 15NO, with L-[urei-
do-15N]-citrulline being the second reaction product. Because authen-
tic 15NO is not detectable at low NOS activity values as in the case of
endothelial NOS (eNOS), analytically accessible metabolites/reaction
products of 15NO are analyzed instead. It must be emphasized that all
eNOS activity assays are exclusively based on the measurement of NO
metabolites/reaction products because of the pretty low NO formation
rate. In aqueous solutions including blood 15NO is autoxidized to 15N-
nitrite (15NO2—), albeit to a minor extent [6]. NOS isozymes are able to
oxidize its own 15NO to 15N-nitrate (O15NO2—) [3]. In aqueous solutions
of recombinant eNOS solutions and in washed human platelets sus-
pensions, the 15NO2—-to-O15NO2— molar ratio is about 1:1 [5]. In human
erythrocytes suspensions in regular buffers of neutral pH value or in
whole blood [6], 15NO-derived 15NO2— is practically undetectable,
because 15NO is rapidly oxidized by oxyhemoglobin (HbFeIIO2) to
O15NO2—. Thus, in RBCs eNOS would convert L-[guanidino-15N2]-argi-
nine to 15NO which would be oxidized to O15NO2— largely by HbFeIIO2
and to a minor extent by eNOS (Fig. 1). In theory, a very small fraction
of L-[guanidino-15N2]-arginine/eNOS-derived 15NO would autoxidize to
15NO2— which would almost uniformly partition between plasma and
RBCs. Erythrocytic 15NO2— would ﬁnally be oxidized to O15NO2— by
HbFeIIO2. This is supported by our observation that synthetic 15NO gas
is oxidized in humanwhole blood to O15NO2— and 15NO2— with a molar
ratio of about 250:1 after 15 min of continuous 15NO bubbling at
2213-2317/& 2015 Published by Elsevier B.V.
n Correspondence to: Centre of Pharmacology and Toxicology, Hannover Medical
School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
E-mail address: tsikas.dimitros@mh-hannover.de
Redox Biology 5 (2015) 409–412
